Portfolio (Quarterly)
Guide ↗
Defilade Capital Management, L.P.
· CIK 0002088557| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | ATRC | ATRICURE INC | Healthcare | 397,636.0 | $15.7M | 2.13% | NEW | — | $39.56 | -27.2% |
| 22 | LIVN | LIVANOVA PLC | Healthcare | 241,413.0 | $14.9M | 2.01% | NEW | — | $61.53 | +17.4% |
| 23 | ATEC | ALPHATEC HLDGS INC | Healthcare | 626,754.0 | $13.2M | 1.79% | NEW | — | $21.04 | -60.9% |
| 24 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 656,713.0 | $10.8M | 1.47% | NEW | — | $16.51 | +11.4% |
| 25 | GKOS | GLAUKOS CORP | Healthcare | 91,703.0 | $10.4M | 1.40% | NEW | — | $112.91 | +25.9% |
| 26 | RXST | RXSIGHT INC | Healthcare | 913,090.0 | $9.5M | 1.29% | NEW | — | $10.42 | -42.4% |
| 27 | ELAN | ELANCO ANIMAL HEALTH INC | Healthcare | 401,283.0 | $9.1M | 1.23% | NEW | — | $22.63 | -11.9% |
| 28 | INSM | INSMED INC | Healthcare | 50,000.0 | $8.7M | 1.18% | NEW | — | $174.04 | -38.4% |
| 29 | OCUL | OCULAR THERAPEUTIX INC | Healthcare | 681,663.0 | $8.3M | 1.12% | NEW | — | $12.14 | -31.0% |
| 30 | TFX | TELEFLEX INCORPORATED | Healthcare | 42,850.0 | $5.2M | 0.71% | NEW | — | $122.04 | +6.9% |
| 31 | ELDN | ELEDON PHARMACEUTICALS INC | Healthcare | 3,290,450.0 | $5.0M | 0.67% | NEW | — | $1.51 | +137.1% |
| 32 | CNMD | CONMED CORP | Healthcare | 104,129.0 | $4.2M | 0.57% | NEW | — | $40.60 | -9.8% |
| 33 | EVMN | EVOMMUNE INC | Healthcare | 215,418.0 | $3.7M | 0.50% | NEW | — | $17.12 | +27.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
93.7%
Financial Services
6.3%